Xeloda (Capecitabine) - Disability - Suspected Cause - Side Effect Reports

Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-08-27

Patient: female, weighing 43.0 kg (94.6 pounds)

Reactions: Thrombosis, Vomiting, Monoplegia, Nausea, Diarrhoea, Oedema Peripheral, Headache

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda

Possible Xeloda side effects in

Reported by a consumer/non-health professional from United States on 2012-08-25

Patient:

Reactions: Death, Ill-Defined Disorder

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Tarceva
    Indication: Brain Neoplasm Malignant

Tarceva

Xeloda
    Indication: Brain Neoplasm Malignant

Xeloda

Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-08-24

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: Stomatitis, Disseminated Intravascular Coagulation, Pancytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Ketoacidosis, Diarrhoea, Cerebral Infarction, Altered State of Consciousness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Tamoxifen Citrate

Possible Xeloda side effects in female

Reported by a physician from Australia on 2012-08-24

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Nausea, Urinary Tract Infection, Atrial Fibrillation, Pyrexia, Anastomotic Leak, Hypokalaemia, Diarrhoea, Ventricular Tachycardia, Dehydration, Hypoalbuminaemia, Decreased Appetite, Anastomotic Fistula

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: last dose prior to sae on 21mar 2011 (50 mg/m2 on day1, 8, 15, 21 and 29).
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Xeloda
    Dosage: last date prior to sae: 26 march 2011 250 mg. (825 mg/m2 bid d1-33 w/o weekends and optional boost),
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Other drugs received by patient: Salmeterol; Colecalciferol; Potassium; Aspirin; Fluticasone Propionate; Pantoprazole; Prednisolone; Methotrexate; Acetaminophen; Metoprolol Tartrate; Diclofenac Sodium; Ferrous Sulfate TAB; Olmesartan Medoxomil; Enoxaparin; Folic Acid; Magnesium; Verapamil; Metoclopramide

Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-08-20

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Anorectal Disorder, Quadriplegia, Bladder Disorder, Multiple Sclerosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Oxaliplatin

Possible Xeloda side effects in 83 year old male

Reported by a pharmacist from Canada on 2012-08-16

Patient: 83 year old male, weighing 60.8 kg (133.8 pounds)

Reactions: Stomatitis, Skin Exfoliation, Pancytopenia, Pyrexia, Erythema, Eating Disorder, Epidermolysis, Burning Sensation, Dyspepsia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Metoclopramide; Senna-Mint WAF; Flomax (Canada); Loperamide; Ciprofloxacin HCL; Magic Mouth Wash (Ingredients Unk)

Possible Xeloda side effects in 68 year old female

Reported by a physician from Japan on 2012-07-19

Patient: 68 year old female

Reactions: Skin Disorder, Palmar-Plantar Erythrodysaesthesia Syndrome

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Tykerb
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Breast Cancer Metastatic

Xeloda
    Administration route: Oral
    Start date: 2011-04-01
    End date: 2011-06-24

Xeloda
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-09-24
    End date: 2011-03-29

Tykerb
    Dosage: amount of 80%
    Administration route: Oral

Tykerb
    Dosage: dosage is uncertain.
    Administration route: Oral

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral

Possible Xeloda side effects in 37 year old female

Reported by a physician from Russian Federation on 2012-07-13

Patient: 37 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Weight Increased, Disease Progression

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Xeloda

Possible Xeloda side effects in male

Reported by a pharmacist from Japan on 2012-06-29

Patient: male, weighing 49.0 kg (107.8 pounds)

Reactions: Disseminated Intravascular Coagulation, Pancytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Ketoacidosis, Cerebral Infarction, Diarrhoea, Oral Mucosa Erosion, Altered State of Consciousness

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Tamoxifen Citrate

Possible Xeloda side effects in female

Reported by a physician from Australia on 2012-06-26

Patient: female, weighing 109.0 kg (239.8 pounds)

Reactions: Nausea, Urinary Tract Infection, Atrial Fibrillation, Pyrexia, Anastomotic Leak, Hypokalaemia, Diarrhoea, Dehydration, Ventricular Tachycardia, Hypoalbuminaemia, Decreased Appetite, Anastomotic Fistula

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: last date prior to sae: 26 march 2011 250 mg. (825 mg/m2 bid d1-33 w/o weekends and optional boost),
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Oxaliplatin
    Dosage: last dose prior to sae on 21mar 2011 (50 mg/m2 on day1, 8, 15, 21 and 29).
    Indication: Rectal Cancer
    Start date: 2011-02-21
    End date: 2011-08-10

Other drugs received by patient: Olmesartan Medoxomil; Salmeterol; Prednisolone; Folic Acid; Aspirin; Ferrous Sulfate TAB; Fluticasone; Colecalciferol; Potassium Acetate; Magnesium Sulfate; Verapamil; Diclofenac Sodium; Methotrexate; Pantoprazole; Metoclopramide; Metoprolol Tartrate; Acetaminophen; Enoxaparin

Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-06-18

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Anorectal Disorder, Quadriplegia, Bladder Disorder, Multiple Sclerosis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Oxaliplatin

Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-06-18

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pruritus, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Start date: 2011-09-12
    End date: 2011-11-13

Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Start date: 2011-12-05
    End date: 2012-02-20

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-12
    End date: 2012-02-20

Xeloda
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2011-11-14
    End date: 2011-12-04

Other drugs received by patient: Crestor; Amlodipine

Possible Xeloda side effects in male

Reported by a physician from Australia on 2012-06-13

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Cerebral Infarction, Hemiplegia

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Gliclazide; Metformin HCL; Panadol Osteo; Lipitor; Irinotecan HCL

Possible Xeloda side effects in male

Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-06-12

Patient: male

Reactions: Blindness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda

Possible Xeloda side effects in 34 year old male

Reported by a physician from China on 2012-06-12

Patient: 34 year old male, weighing 55.0 kg (121.0 pounds)

Reactions: Neck Pain, Deafness, Condition Aggravated, Headache, Blindness, Metastases To Central Nervous System

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Celebrex
    Administration route: Oral
    Start date: 2011-12-30
    End date: 2011-12-31

Eloxatin
    Start date: 2011-12-01
    End date: 2011-12-01

Eloxatin
    Start date: 2011-09-02
    End date: 2011-09-02

Xeloda
    Dosage: from day 1 to day 14.
    Administration route: Oral
    Start date: 2011-09-02
    End date: 2011-12-01

Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-06-06

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Interstitial Lung Disease, Pneumomediastinum, Subcutaneous Emphysema

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Interstitial Lung Disease
    Start date: 2012-02-07
    End date: 2012-02-23

Avastin
    Indication: Rectal Cancer Metastatic
    Start date: 2011-07-15
    End date: 2011-12-01

Xeloda
    Dosage: the seventh administering/ on the 14th
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2011-07-15
    End date: 2012-01-20

Prednisolone
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-07

Methylprednisolone Sodium Succinate
    Indication: Interstitial Lung Disease
    Start date: 2012-02-04
    End date: 2012-02-06

Prednisolone
    Administration route: Oral
    Start date: 2012-03-08

Oxaliplatin
    Indication: Rectal Cancer Metastatic
    Start date: 2011-07-15
    End date: 2012-01-01

Other drugs received by patient: Glufast; Metformin Hydrochloride; Warfarin Sodium; Losartan Potassium; Halfdigoxin KY; Nizatidine

Possible Xeloda side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-05-23

Patient: female

Reactions: Uterine Cancer, Urinary Tract Infection, Anaemia, Meningitis Bacterial, Leukoencephalopathy, Liver Disorder

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-08-01
    End date: 2010-12-12

Cefpirome Sulfate
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-13
    End date: 2010-12-20

Cyclophosphamide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-02-01
    End date: 2010-12-12

Cefpirome Sulfate
    Administration route: Oral
    End date: 2010-12-12

Other drugs received by patient: Mucosta; Tocopherol Concentrate CAP; Celestamine TAB; Meloxicam; Hirudoid; Cyclophosphamide; Neurovitan (Ukraine); Atines

Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-22

Patient: female

Reactions: Anxiety, Diarrhoea, Dizziness, Palmar-Plantar Erythrodysaesthesia Syndrome, Gait Disturbance, Suicidal Ideation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Effexor XR
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Keppra
    Indication: Product Used FOR Unknown Indication

Ativan
    Indication: Product Used FOR Unknown Indication

Keppra

Other drugs received by patient: Herceptin

Possible Xeloda side effects in 56 year old female

Reported by a consumer/non-health professional from Canada on 2012-05-15

Patient: 56 year old female

Reactions: Vomiting Projectile, Pain in Extremity, Quality of Life Decreased, Rhinorrhoea, Balance Disorder, Visual Impairment, Gait Disturbance, Ophthalmological Examination Abnormal, Blindness, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda

Possible Xeloda side effects in female

Reported by a physician from Finland on 2012-05-09

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Gastrointestinal Mucosal Exfoliation, Neutropenic Sepsis, Enterobacter Sepsis, Encephalopathy, Pyrexia, Ketoacidosis, Diarrhoea, Thrombocytopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Docetaxel; Insulin

Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-05-03

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Pneumonia Bacterial

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: 3000mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-23
    End date: 2011-05-30

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Start date: 2011-06-25
    End date: 2011-12-16

Xeloda
    Dosage: 3000mg per day
    Administration route: Oral
    Start date: 2011-06-25
    End date: 2011-12-16

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-04-23

Tykerb
    Administration route: Oral
    Start date: 2011-05-14

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    End date: 2011-05-30

Other drugs received by patient: Pydoxal

Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-05-02

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Pruritus, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Start date: 2011-12-05
    End date: 2012-02-20

Xeloda
    Dosage: 1200mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-12
    End date: 2011-11-13

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-12
    End date: 2012-02-20

Xeloda
    Dosage: 900mg per day
    Administration route: Oral
    Start date: 2011-11-14
    End date: 2011-12-04

Other drugs received by patient: Amlodipine; Crestor

Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-04-30

Patient: male

Reactions: Cerebral Infarction

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Large Intestine Carcinoma
    Start date: 2012-01-01

Avastin
    Dosage: dosage is uncertain.
    Indication: Colorectal Cancer
    Start date: 2011-12-10
    End date: 2011-12-10

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Colorectal Cancer
    End date: 2011-12-01

Other drugs received by patient: Oxaliplatin

Possible Xeloda side effects in male

Reported by a physician from Belgium on 2012-04-27

Patient: male, weighing 63.3 kg (139.3 pounds)

Reactions: Anaemia, International Normalised Ratio Increased, Colitis, Hypokalaemia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Avastin
    Indication: Rectal Cancer

Xeloda
    Indication: Rectal Cancer

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2012-02-13

Xeloda
    Administration route: Oral
    Indication: Colon Cancer
    Start date: 2012-02-13

Avastin
    Indication: Colon Cancer
    Start date: 2012-02-13

Oxaliplatin
    Indication: Rectal Cancer

Possible Xeloda side effects in male

Reported by a physician from Japan on 2012-04-20

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Jaundice, Bile Duct Stenosis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15
    End date: 2010-10-13

Oxaliplatin
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent
    Start date: 2009-12-15

Erbitux
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Recurrent

Other drugs received by patient: Novorapid; Lantus; Pydoxal

Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Doxorubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01

Possible Xeloda side effects in male

Reported by a individual with unspecified qualification from Mexico on 2012-04-18

Patient: male

Reactions: Neurotoxicity, Palmar-Plantar Erythrodysaesthesia Syndrome, Blindness

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral

Xeloda
    Administration route: Oral

Xeloda
    Administration route: Oral
    Indication: Gastrointestinal Cancer Metastatic
    Start date: 2011-03-01

Xeloda
    Administration route: Oral

Possible Xeloda side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-17

Patient: 43 year old female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: unk
    Start date: 2011-03-11
    End date: 2011-07-01

Tamoxifen Citrate
    Dosage: unk
    Administration route: Oral
    Start date: 2007-06-01
    End date: 2008-04-01

Aromasin
    Dosage: unk
    Administration route: Oral
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Dosage: unk
    Start date: 2006-11-17
    End date: 2007-01-05

Avastin
    Dosage: unk
    Start date: 2010-08-01
    End date: 2010-11-01

Epirubicin Hydrochloride
    Dosage: 100 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Femara
    Dosage: unk
    Administration route: Oral
    Start date: 2008-04-01
    End date: 2010-08-01

Cyclophosphamide
    Dosage: 500 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Dosage: unk
    Start date: 2010-11-01
    End date: 2011-01-26

Fluorouracil
    Dosage: 500 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Dosage: unk
    Start date: 2010-03-26
    End date: 2010-07-16

Xeloda
    Dosage: unk
    Administration route: Oral
    Start date: 2010-11-01
    End date: 2011-01-01

Taxotere
    Dosage: unk
    Start date: 2010-03-26
    End date: 2010-07-16

Possible Xeloda side effects in female

Reported by a physician from France on 2012-04-13

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-06-01
    End date: 2008-04-01

Femara
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-04-01
    End date: 2010-08-01

Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-11-01
    End date: 2011-01-01

Cyclophosphamide
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Doxorubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-11
    End date: 2011-07-01

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Start date: 2010-11-01
    End date: 2011-01-26

Avastin
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-26
    End date: 2010-07-01

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Taxotere
    Dosage: 6 cycles
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-11-17
    End date: 2007-01-05

Taxotere
    Dosage: 6 cycles
    Start date: 2010-03-26
    End date: 2010-07-16

Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-12

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27